Port Hueneme, CA, United States of America

Evan Kruchowy

This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Amgen Inc.. Active years: 2026.

USPTO Granted Patents = 2 

% Patents Active = 50.0

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Evan Kruchowy

Introduction

Evan Kruchowy is an accomplished inventor based in Port Hueneme, California. He has made significant contributions to the field of automated quality control systems, particularly in the medical device sector. His innovative work focuses on enhancing the quality evaluation of syringes used in medication delivery.

Latest Patents

Evan holds a patent for "Methods and systems for automated syringe quality evaluation." This patent describes automatic syringe quality control systems, apparatus, and methods that determine the plunger depth within a syringe that has been pre-filled with medication. The determination of plunger depth is based on digital image data, which enhances the accuracy and reliability of syringe quality assessments.

Career Highlights

Evan is currently employed at Amgen Inc., a leading biotechnology company known for its innovative approaches to healthcare. His work at Amgen has allowed him to apply his expertise in developing advanced quality control systems that ensure the safety and efficacy of medical devices.

Collaborations

Evan collaborates with talented professionals in his field, including Vikashni Padmakumar and Daniel Coller. These collaborations foster a creative environment that drives innovation and enhances the development of new technologies.

Conclusion

Evan Kruchowy's contributions to automated syringe quality evaluation exemplify the impact of innovation in the medical device industry. His work not only improves quality control processes but also ensures better patient outcomes through enhanced safety measures.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…